Corporate Finance & Consulting  
 
 
Home Page > Replicon Group
 



Replicon Extends Its Life Science Expert Team
26-01-2005,

Replicon extends its Life Science expert team. Katariina Hannula-Jouppi (MD, PhD, MBA) joins our 'Other Professionals' team that works for Replicon on project basis. Katariina is specialized in genetics. She has already taken part in two separate projects within Replicon.

To emphasize the broad range of Replicon expertise in Life Science sector, we have launched a project for updating, documentation and further development of Replicon Biotech Value model portfolio (RBV, see earlier news on 29th of Jan., 2004 and 28th of Jan., 2003). CEO Petteri Hirvonen and Marjatta Rytömaa (PhD in bio chemistry) will finalize this project by March 2005. Marjatta Rytömaa will use this analyses/report for her MBA graduation work. The report will inter alia contain analyses on the performance of this model portfolio for the first 2 years starting from January 2003.

Replicon team possesses now Life Science specialists in the field of Big Pharma experince, clinical trials, diagnostics, genetics, biochemistry, bioinformatics, project valuations, etc. A non exhaustive list of Replicon's professionals and individual biographies can be found in Professionals.

More details on these pieces of news and full details of Replicon services are available on our web page or on request.

For further information, please contact:
Replicon Oy
Petteri Hirvonen, CEO
+358 9 677 464 +358 50 552 96 33
petteri.hirvonen@replicon.fi

Replicon Group provides strategic and financial solutions that facilitate business activities, efficiency, and increase profitability of corporations and other organizations. Our core competence is in the corporate solutions that facilitate and govern growth. An important part of our activities is continuous learning. We want to find and develop most suitable solutions to our customer needs. Replicon Group's special focus areas are Life-Science and Mobile/ICT -sectors The main shareholders in Replicon companies are its key management. Replicon's homepage is www.replicon.fi


Recent articles:

> 19-08-2010 - Valuation Services and Total Life Cycle Cost Analyses

> 04-05-2010 - Oversol Oy / Lumi Group Oy Raises First Part of 2-4 M€ Financing

> 22-03-2010 - Replicon Continues as Certified Adviser in NASDAQ OMX First North

> 22-03-2010 - Replicon Group jatkaa NASDAQ OMX:ssä neuvonantajana

> 22-01-2010 - Replicon Initiates Multimillion Financing Project for Promising LED Application

> 06-10-2009 - Replicon Newsletter Q3/2009

> 09-09-2009 - New Certification for Replicon Group

> 24-08-2009 - Replicon toimittaa asiantuntija-palvelupaketin Qentinel Oy:lle

> 17-08-2009 - ASIAVIIHDE: videoidut talouskirja-arvostelut

> 16-06-2009 - Replicon Group Company Awarded 2 Year R&D Project

> 21-05-2009 - Replicon Newsletter Q2/2009

> 21-05-2009 - Repliconin Uutiskirje Q2/2009

> 03-02-2009 - Replicon Newsletter Q1/2009

> 19-01-2009 - Jouko Ahvenainen Presenting in Mobile World Congress in Barcelona

> 19-12-2008 - Replicon Creates an Option Arrangement for Its Client

> 29-10-2008 - Results from Client Survey

> 18-09-2008 - Tuottavuus ja rahoitus 2008 -seminaari

> 17-06-2008 - Ani Biotech buys the Business Operations of Orgenium Laboratories

> 20-05-2008 - Tietoisku FIRST NORTH -markkinapaikasta

> 31-03-2008 - Replicon Collaboration Partner Forms Global Multi-Centre Network

> 30-01-2008 - Replicon helps EVE to Receive Private Equity Financing

> 29-01-2008 - Replicon Pharma Portfolio Outperforms Benchmark Index Fifth Year in a Row

> 29-11-2007 - Replicon Group OMX First Northin Certified Adviseriksi

> 29-11-2007 - Replicon Group becomes Certified Adviser in OMX First North

> 28-11-2007 - Matti Copeland Repliconin neuvonantajaksi

> 15-10-2007 - Replicon Private Equity -tapahtuma

> 24-09-2007 - Talentor Receives Private Equity Financing Package in Record Time

> 07-08-2007 - Meet Replicon in Autumn 2007

> 11-05-2007 - Replicon and Imanext Form Strategic Collaboration

> 17-04-2007 - Pääjohtaja Liikanen puhumassa Repliconin Tuottavuus -seminaarissa

> 17-04-2007 - BoF Governor Speaking at Replicon Productivity Seminar

> 09-03-2007 - Top Seminar: ICT Companies as Productivity Boosters

> 08-03-2007 - Xtract raises € 2 million in venture capital funding from Eqvitec

> 21-02-2007 - ICT-yritykset tuottavuuden nostajina - Repliconin Tuottavuus ja rahoitus -seminaari 17.4.2007

> 29-01-2007 - Replicon MDF Portfolio Outperforms Benchmark Index Fourth Year in a Row

> 29-01-2007 - Repliconin Pharma portfolio (MDF) ylittänyt jälleen vertailuindeksin tuoton

> 08-01-2007 - Replicon toimittaa asiantuntijapalvelupaketin Qentinel Oy:lle

> 15-12-2006 - Replicon Provides Expert Services for Xtract, Ltd.

> 01-11-2006 - Replicon Provides Compensation Arrangement Planning for Growth Companies

> 01-11-2006 - Replicon toteuttaa osakesidonnaisia kannustinjärjestelmiä kasvuyrityksille

> 26-10-2006 - Petteri Hirvonen Presenting in Global UMTS TDD Alliance Summit in London

> 28-09-2006 - Jouko Ahvenainen Presenting in Mobile Marketing Service Summit in Lisbon

> 29-05-2006 - First Half Management Consulting Projects of Replicon

> 01-04-2006 - Replicon Launches Investigational Asset Management Portfolio in ICT sector

> 02-03-2006 - Enfucell Receives First VC Round of Financing

> 20-02-2006 - Replicon Helps Arranging Significant Financing Package for a Client

> 29-01-2006 - Replicon Portfolio Outperforms Benchmark Third Year in a Row

> 02-01-2006 - Replicon Hires Satu Vapaakallio as Analyst

> 24-11-2005 - Replicon Initiate 7.5Meur Private Placement Process for SkyWeb Oy

> 14-10-2005 - CTT Cancer Targeting Technologies Ltd enters into R&D agreement with GE Healthcare

> 05-09-2005 - Orgenium receives financing from Abroad and Expands Production to Low Cost Production Site in Ankara, Turkey

> 20-07-2005 - Replicon helps arranging financing for #CMAX.gg

> 31-03-2005 - Replicon in BioFinland 05 Investor Forum

> 29-01-2005 - Replicon Biotech Value Portfolio Outperforms NASDAQ Biotech Index Second Year in a Row

> 26-01-2005 - Replicon Extends Its Life Science Expert Team

> 18-01-2005 - All Replicon Senior Partners Gain Accreditation by the Ministry of Trade and Industry

> 10-01-2005 - Jouko Ahvenainen (MBA, M.Sc.) joins Replicon as a Senior Partner

> 17-12-2004 - Replicon to Develop a Model for Enhancing Commercialization of Bone Research in Finland

> 29-10-2004 - Replicon moves to WTC Helsinki

> 15-10-2004 - MBA Petri Laulajainen joins Replicon as a Senior Partner

> 02-07-2004 - Orgenium closes financing round with private investors and Finnish Industry Investment Ltd.

> 27-05-2004 - Replicon's new strategic partners announced

> 07-04-2004 - Viope closes financing round for expansion

> 29-01-2004 - Replicon Biotech Model Portfolio Annual Return 78 per cent

> 15-12-2003 - Replicon enters into a two-year business development partnership

> 19-08-2003 - Dr. Hannu Silvennoinen joins as a Senior Partner

> 09-04-2003 - Replicon forms corporate finance unit

> 28-01-2003 - Replicon Launches Model Portfolio in Biotech

 
© 2003, Replicon